ClinicalTrials.Veeva

Menu

Changes in the Microbiome Associated With Transplantation

NHS Foundation Trust logo

NHS Foundation Trust

Status

Enrolling

Conditions

Microbiota

Treatments

Other: Sample Collection

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

To study the effects of organ transplantation and immunosuppression on the human microbiome, and to understand the interlinkage of changes in the microbiome with clinical events surrounding transplantation, and graft and patient clinical outcomes.

Full description

This study will involve the collection of oral swabs, saliva, urine and rectal swabs, blood and skin scrapings from patients before and after kidney and pancreas transplantation. At Day 0 and day 1, week 1, and at 3, 6, and 12 months.

These samples will be collected longitudinally over a period of one year after transplantation and will be analysed using 16s rRNA gene sequencing in order to capture the dynamics of the microbiome after exposure to surgery, immunosuppression and the specific medication necessary during the process of transplantation.

Two groups of recipients will be recruited, the first one includes kidney and/or pancreas transplant recipients from both deceased and living donors.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Over 18 years of age.
  • Under 75 years
  • Participants must be able to receive and understand English verbal and written information regarding the study and give written, informed consent.
  • Participants will be recipients of pancreas or kidney allografts

Exclusion criteria

  • Outside of stated age range.
  • Unable to give informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Titus Augustine, FRCP; Angela Dr Summers, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems